人間および動物の健康のための感染管理の世界市場：製品タイプ (消毒製品・個人保護具・滅菌装置)・感染タイプ・エンドユーザー別の予測 (～2032年)

人間および動物の健康のための感染管理の市場規模は、2023年の95億6,000万米ドルから、予測期間中は8.16％のCAGRで推移し、2032年には209億5,000万米ドルの規模に成長すると予測されています。

感染症の流行は、人間および動物の健康のための感染管理の市場の主要な促進要因です。近年、世界中で多くの感染症の発生頻度が著しく増加しており、感染管理製品や手法に対する需要が増加しています。

感染管理技術に対する意識の高まりは、人間および動物の健康市場の主要な促進要因です。近年のパンデミックや世界的な健康上の危機により、感染予防の必要性に対する市民や専門家の意識が高まっています。メディア報道の増加、教育キャンペーン、政府の施策などはすべて、市民とヘルスケアコミュニティの知識向上に寄与しています。個人も医療専門家も、感染症の蔓延を防ぐための消毒製品、個人防護具 (PPE)、滅菌機器の必要性を理解しています。病院、診療所、公共施設など、多くの場面で感染管理が重視されるようになったことで、革新的で効果的な感染管理システムの需要が増加しています。

地域別インサイト

北米地域は2022年に33.75%超で最大のシェアを示しました。これは同地域の高度な医療インフラ、厳しい規制、感染管理に対する高い意識、手術件数の増加によるものです。PPEは整形外科手術において、患者とヘルスケアスタッフの両方の感染を防ぐために多く使用されています。

欧州の人間および動物の健康のための感染管理の市場は、欧州全域での感染症例の増加により、予測期間に大幅な拡大が見込まれています。

アジア太平洋地域は活気に満ちた多様な市場です。人口が急増し、都市化が進み、医療関連の基準に対する意識が高まる中、効果的な感染予防・管理戦略の必要性が高まっています。

当レポートでは、世界の人間および動物の健康のための感染管理の市場を調査し、市場の定義と概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 市場概要

第2章 調査手法

第3章 市場力学

• 概要
• 促進要因
  • 感染症の蔓延の増加
  • 感染管理対策への意識の高まり
• 抑制要因
  • 感染管理におけるコスト上の制約
• 機会
  • 技術的に進歩した持続可能な感染管理ソリューションに対する需要の高まり

第4章 市場要因分析

• バリューチェーン分析
• ポーターのファイブフォース分析
• COVID-19が市場に与える影響

第5章 世界の人間および動物の健康のための感染管理市場：製品別

• 概要
• 消毒製品
  • 液体消毒剤
  • 消毒用ワイプ
  • 消毒スプレー
  • その他
• 個人保護具 (PPE)
  • 手袋
  • マスク
  • ガウン
  • 保護メガネ
  • その他
• 滅菌装置
  • 加熱殺菌装置
  • 低温殺菌装置
  • 放射線滅菌装置
  • 濾過滅菌装置
  • その他

第6章 世界の人間および動物の健康のための感染管理市場：感染タイプ別

• 概要
• ウイルス性
• 細菌性
• 寄生虫
• 真菌感染症

第7章 世界の人間および動物の健康のための感染管理市場：エンドユーザー別

• 概要
• 人間のヘルスケア施設
  • 病院・クリニック
  • 外来手術センター
  • その他
• 動物のヘルスケア施設
  • 獣医
  • 動物保護施設
  • 農業施設
  • その他

第8章 世界の人間および動物の健康のための感染管理市場：地域別

• 概要
• 北米
• 欧州
• アジア太平洋
• その他の地域

第9章 競合情勢

• 市場シェア分析
• 競合ダッシュボード
• 公開企業の株式概要
• 比較分析：主要企業の財務データ
• 主な展開と成長戦略

第10章 企業プロファイル

• 3M
• ZOETIS ANIMAL HEALTHCARE
• PEROTECH SCIENCES INC.
• STERIS PLC
• GETINGE AB
• VIROX TECHNOLOGIES, INC.
• ADVANCED STERILIZATION PRODUCTS
• NEOGEN CORPORATION
• CARDINAL HEALTH
• STRYKER

第11章 データの引用

LIST OF TABLES

• TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 4 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LIQUID DISINFECTANTS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT WIPES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT SPRAYS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 9 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY REGION, 2019-2032 (USD MILLION)
• TABLE 10 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE, 2019-2032 (USD MILLION)
• TABLE 11 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GLOVES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 12 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY MASKS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 13 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GOWNS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 14 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PROTECTIVE EYEWEAR, BY REGION, 2019-2032 (USD MILLION)
• TABLE 15 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 16 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 17 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 18 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HEAT STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
• TABLE 19 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
• TABLE 20 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY RADIATION STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
• TABLE 21 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FILTRATION STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
• TABLE 22 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 23 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 24 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VIRAL, BY REGION, 2019-2032 (USD MILLION)
• TABLE 25 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY BACTERIAL, BY REGION, 2019-2032 (USD MILLION)
• TABLE 26 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PARASITIC, BY REGION, 2019-2032 (USD MILLION)
• TABLE 27 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FUNGAL INFECTIONS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 28 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 29 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 30 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 31 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 32 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 33 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 34 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 35 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 36 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VETERINARY HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 37 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL SHELTERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 38 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FARMING FACILITIES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 39 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 40 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 41 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 42 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 43 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 44 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 45 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 46 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 47 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 48 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 49 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 50 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 51 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 52 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 53 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 54 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 55 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 56 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 57 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 58 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 59 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 60 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 61 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 62 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 63 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 64 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 65 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 66 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 67 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 68 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 69 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 70 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 71 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 72 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 73 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 74 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 75 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 76 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 77 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 78 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 79 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 80 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 81 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 82 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 83 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 84 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 85 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 86 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 87 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 88 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 89 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 90 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 91 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 92 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 93 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 94 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 95 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 96 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 97 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 98 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 99 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 100 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 101 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 102 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 103 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 104 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 105 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 106 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 107 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 108 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 109 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 110 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 111 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 112 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 113 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 114 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 115 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 116 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
• TABLE 117 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
• TABLE 118 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
• TABLE 119 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 120 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 121 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 122 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
• TABLE 123 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 124 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 125 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 126 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 127 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 128 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 129 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 130 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 131 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 132 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 133 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 134 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 135 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 136 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 137 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 138 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 139 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 140 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 141 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 142 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 143 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 144 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 145 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 146 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 147 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 148 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 149 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 150 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 151 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 152 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 153 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 154 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 155 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 156 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 157 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 158 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 159 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 160 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 161 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 162 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 163 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 164 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 165 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 166 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 167 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 168 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 169 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 170 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 171 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 172 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 173 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 174 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 175 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 176 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 177 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 178 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 179 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 180 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 181 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 182 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 183 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 184 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 185 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 186 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 187 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 188 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 189 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 190 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 191 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 192 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 193 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 194 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 195 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 196 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 197 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
• TABLE 198 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 199 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 200 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 201 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
• TABLE 202 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 203 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 204 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 205 PUBLIC PLAYERS STOCK SUMMARY
• TABLE 206 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• TABLE 207 PRODUCT LAUNCH
• TABLE 208 3M: PRODUCTS OFFERED
• TABLE 209 ZOETIS ANIMAL HEALTHCARE: PRODUCTS OFFERED
• TABLE 210 PEROTECH SCIENCES INC.: PRODCUTS OFFERED
• TABLE 211 STERIS PLC: PRODCUTS OFFERED
• TABLE 212 GETINGE AB: PRODUCTS OFFERED
• TABLE 213 VIROX TECHNOLOGIES, INC.: PRODUCTS OFFERED
• TABLE 214 ADVANCED STERILIZATION PRODUCTS: PRODUCTS OFFERED
• TABLE 215 ADVANCED STERILIZATION PRODUCTS: KEY DEVELOPMENTS
• TABLE 216 NEOGEN CORPORATION: PRODUCT OFFERED
• TABLE 217 NEOGEN CORPORATION: KEY DEVELOPMENTS
• TABLE 218 CARDINAL HEALTH: PRODUCT OFFERED
• TABLE 219 CARDINAL HEALTH: KEY DEVELOPMENTS
• TABLE 220 STRYKER: PRODUCT OFFERED
• TABLE 221 STRYKER: KEY DEVELOPMENTS

LIST OF FIGURES

• FIGURE 1 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET: STRUCTURE
• FIGURE 2 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
• FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
• FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
• FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
• FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
• FIGURE 7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)
• FIGURE 8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT,
• FIGURE 9 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2022 & 2032 (USD MILLION)
• FIGURE 10 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY INFECTION TYPE,
• FIGURE 11 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2022 & 2032 (USD MILLION)
• FIGURE 12 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY END USER,
• FIGURE 13 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2022 & 2032 (USD MILLION)
• FIGURE 14 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY REGION,
• FIGURE 15 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
• FIGURE 16 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY,
• FIGURE 17 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
• FIGURE 18 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY,
• FIGURE 19 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
• FIGURE 20 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY,
• FIGURE 21 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2022 & 2030 (USD MILLION)
• FIGURE 22 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY REGION,
• FIGURE 23 INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS,
• FIGURE 24 COMPETITOR DASHBOARD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET
• FIGURE 25 3M: FINANCIAL OVERVIEW
• FIGURE 26 3M: SWOT ANALYSIS
• FIGURE 27 ZOETIS ANIMAL HEALTHCARE: PRODUCTS OFFERED
• FIGURE 28 ZOETIS ANIMAL HEALTHCARE: SWOT ANALYSIS
• FIGURE 29 STERIS PLC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 30 STERIS PLC: SWOT ANALYSIS
• FIGURE 31 GETINGE AB: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 32 GETINGE AB: SWOT ANALYSIS
• FIGURE 33 NEOGEN CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 34 NEOGEN CORPORATION: SWOT ANALYSIS
• FIGURE 35 CARDINAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 36 STRYKER: FINANCIAL OVERVIEW SNAPSHOT

Global Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protective Eyewear, and Others], and Sterilization Equipment [Heat Sterilization Equipment, Low-temperature Sterilization Equipment, Radiation Sterilization Equipment, and Filtration Sterilization Equipment]), by Infection Type (Viral, Bacterial, Parasitic, and Fungal Infections), by End Us (Human Healthcare Facilities and Animal Healthcare facilities)- Forecast to 2032

Market Overview

The Infection Control for Human and Animal Health Market industry is expected to increase from USD 9.56 billion in 2023 to USD 20.95 billion by 2032, with a compound yearly growth rate (CAGR) of 8.16% over the forecast period (2023-2032).

The rising prevalence of infectious diseases is a major driver of infection control in the human and animal health markets. In recent years, there has been a significant increase in the frequency of numerous infectious diseases around the world, resulting in increased demand for infection control products and methods.

Rising awareness of infection control techniques is a key driver for the human and animal health markets. The recent pandemics and global health crises have heightened public and professional awareness of the necessity of infection prevention. Increased media coverage, educational campaigns, and government measures have all contributed to a better knowledgeable public and healthcare community. Individuals and healthcare professionals alike understand the need of disinfection products, personal protective equipment (PPE), and sterilizing equipment in preventing the spread of infectious diseases. The rising emphasis on infection control practices in many contexts, including hospitals, clinics, and public areas, has resulted in an increase in demand for innovative and effective infection control systems.

Market Segment insights

The Infection Control for Human and Animal Health Market is divided into three product categories: disinfection, personal protective equipment (PPE), and sterilization.

The market has been divided into four types of infections: viral, bacterial, parasitic, and fungal.

The market is divided into two segments based on end users: human healthcare facilities and animal healthcare facilities.

Regional insights

North America had the biggest market share of more than 33.75% in 2022, owing to the region's sophisticated healthcare infrastructure, tight regulations, high awareness of infection control measures, and increasing number of surgical procedures. PPE is often used in orthopedic surgery to avoid infections in both patients and healthcare staff. According to the American Joint Replacement Registry's annual report for 2021, 2,244,587 hip and knee operations were conducted.

Europe's infection control market for human and animal health is expected to rise significantly during the forecast year, 2022-2023, due to an increase in infection cases across Europe. The infection control industry in Europe, which includes both human and animal health, is seeing a significant spike, driven by increased awareness of infectious illnesses and the demand for better preventive measures. According to the World Health Organization, on June 26, 2023, Croatia, Italy, Spain, Sweden, and the United Kingdom of Great Britain and Northern Ireland reported an increase in confirmed cases of E-11 infection in neonates and babies, with substantial morbidity and death.

The Asia-Pacific area is a vibrant and diversified market for infection control in human and animal health. With a fast-growing population, more urbanization, and rising awareness of healthcare standards, there is a greater need for effective infection prevention and control strategies. According to the United Nations Population Fund (UNFPA), Asia and the Pacific make up 60% of the world's population, or around 4.3 billion people.

Major Players

Advanced Sterilization Products (US), STERIS plc (Ireland), Getinge AB (Sweden), Virox Technologies, Inc. (Canada), 3M (US), Zoetis Animal Healthcare (US), PeproTech Sciences Inc (Canada), Neogen Corporation (US), Cardinal Health (US), and Stryker (US) are among the key players in the Infection Control for Human and Animal Health Market.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1 DEFINITION
• 1.2 SCOPE OF THE STUDY
• 1.3 RESEARCH OBJECTIVE
• 1.4 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

• 2.1 OVERVIEW
• 2.2 DATA FLOW
  • 2.2.1 DATA MINING PROCESS
• 2.3 PURCHASED DATABASE:
• 2.4 SECONDARY SOURCES:
  • 2.4.1 SECONDARY RESEARCH DATA FLOW:
• 2.5 PRIMARY RESEARCH:
  • 2.5.1 PRIMARY RESEARCH DATA FLOW:
  • 2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
• 2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 2.6.1 REVENUE ANALYSIS APPROACH
• 2.7 DATA FORECASTING
  • 2.7.1 DATA FORECASTING TECHNIQUE
• 2.8 DATA FORMULATIONLING
  • 2.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 2.8.2 DATA FORMULATIONLING:
• 2.9 TEAMS AND ANALYST CONTRIBUTION

3 MARKET DYNAMICS

• 3.1 INTRODUCTION
• 3.2 DRIVERS
  • 3.2.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES
  • 3.2.2 RISING AWARENESS OF INFECTION CONTROL MEASURES
• 3.3 RESTRAINTS
  • 3.3.1 COST CONSTRAINTS IN INFECTION CONTROL
• 3.4 OPPORTUNITY
  • 3.4.1 GROWING DEMAND FOR TECHNOLOGICALLY ADVANCED AND SUSTAINABLE INFECTION CONTROL SOLUTIONS

4 MARKET FACTOR ANALYSIS

• 4.1 VALUE CHAIN ANALYSIS
  • 4.1.1 R&D
  • 4.1.2 MANUFACTURING
  • 4.1.3 DISTRIBUTION AND SALES
  • 4.1.4 POST-SALES MONITORING
• 4.2 PORTER'S FIVE FORCES MODEL
  • 4.2.1 THREAT OF NEW ENTRANTS
  • 4.2.2 BARGAINING POWER OF SUPPLIERS
  • 4.2.3 THREAT OF SUBSTITUTES
  • 4.2.4 BARGAINING POWER OF BUYERS
  • 4.2.5 INTENSITY OF RIVALRY
• 4.3 IMPACT OF COVID-19 ON THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
  • 4.3.1 IMPACT ON SUPPLY CHAIN
  • 4.3.2 IMPACT ON MARKET PLAYERS

5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT

• 5.1 OVERVIEW
• 5.2 DISINFECTION PRODUCTS
  • 5.2.1 LIQUID DISINFECTANTS
  • 5.2.2 DISINFECTANT WIPES
  • 5.2.3 DISINFECTANT SPRAYS
  • 5.2.4 OTHERS
• 5.3 PERSONAL PROTECTIVE EQUIPMENT (PPE)
  • 5.3.1 GLOVES
  • 5.3.2 MASKS
  • 5.3.3 GOWNS
  • 5.3.4 PROTECTIVE EYEWEAR
  • 5.3.5 OTHERS
• 5.4 STERILIZATION EQUIPMENT
  • 5.4.1 HEAT STERILIZATION EQUIPMENT
  • 5.4.2 LOW-TEMPERATURE STERILIZATION EQUIPMENT
  • 5.4.3 RADIATION STERILIZATION EQUIPMENT
  • 5.4.4 FILTRATION STERILIZATION EQUIPMENT
  • 5.4.5 OTHERS

6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE

• 6.1 OVERVIEW
• 6.2 VIRAL
• 6.3 BACTERIAL
• 6.4 PARASITIC
• 6.5 FUNGAL INFECTIONS

7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER

• 7.1 OVERVIEW
• 7.2 HUMAN HEALTHCARE FACILITIES
  • 7.2.1 HOSPITALS & CLINICS
  • 7.2.2 AMBULATORY SURGICAL CENTERS
  • 7.2.3 OTHERS
• 7.3 ANIMAL HEALTHCARE FACILITIES
  • 7.3.1 VETERINARY HOSPITALS
  • 7.3.2 ANIMAL SHELTERS
  • 7.3.3 FARMING FACILITIES
  • 7.3.4 OTHERS

8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 US
  • 8.2.2 CANADA
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 FRANCE
  • 8.3.3 UK
  • 8.3.4 ITALY
  • 8.3.5 SPAIN
  • 8.3.6 REST OF EUROPE
• 8.4 ASIA-PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 INDIA
  • 8.4.3 JAPAN
  • 8.4.4 AUSTRALIA
  • 8.4.5 SOUTH KOREA
  • 8.4.6 REST OF ASIA-PACIFIC
• 8.5 REST OF THE WORLD
  • 8.5.1 REST OF THE WORLD
  • 8.5.2 MIDDLE EAST & AFRICA
  • 8.5.3 SOUTH AMERICA

9 COMPETITIVE LANDSCAPE

• 9.1 INTRODUCTION
• 9.2 MARKET SHARE ANALYSIS,
• 9.3 COMPETITOR DASHBOARD
• 9.4 PUBLIC PLAYERS STOCK SUMMARY
• 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 9.6.1 PRODUCT LAUNCH

10 COMPANY PROFILE

• 10.1 3M
  • 10.1.1 COMPANY OVERVIEW
  • 10.1.2 FINANCIAL OVERVIEW
  • 10.1.3 PRODUCTS OFFERED
  • 10.1.4 KEY DEVELOPMENTS
  • 10.1.5 SWOT ANALYSIS
  • 10.1.6 KEY STRATEGIES
• 10.2 ZOETIS ANIMAL HEALTHCARE
  • 10.2.1 COMPANY OVERVIEW
  • 10.2.2 FINANCIAL OVERVIEW
  • 10.2.3 PRODUCTS OFFERED
  • 10.2.4 KEY DEVELOPMENTS
  • 10.2.5 SWOT ANALYSIS
  • 10.2.6 KEY STRATEGIES
• 10.3 PEROTECH SCIENCES INC.
  • 10.3.1 COMPANY OVERVIEW
  • 10.3.2 FINANCIAL OVERVIEW
  • 10.3.3 PRODUCTS OFFERED
  • 10.3.4 KEY DEVELOPMENTS
  • 10.3.5 KEY STRATEGIES
• 10.4 STERIS PLC
  • 10.4.1 COMPANY OVERVIEW
  • 10.4.2 FINANCIAL OVERVIEW
  • 10.4.3 PRODUCTS OFFERED
  • 10.4.4 KEY DEVELOPMENTS
  • 10.4.5 SWOT ANALYSIS
  • 10.4.6 KEY STRATEGY
• 10.5 GETINGE AB
  • 10.5.1 COMPANY OVERVIEW
  • 10.5.2 FINANCIAL OVERVIEW
  • 10.5.3 PRODUCTS OFFERED
  • 10.5.4 KEY DEVELOPMENTS
  • 10.5.5 SWOT ANALYSIS
  • 10.5.6 KEY STRATEGY
• 10.6 VIROX TECHNOLOGIES, INC.
  • 10.6.1 COMPANY OVERVIEW
  • 10.6.2 FINANCIAL OVERVIEW
  • 10.6.3 PRODUCTS OFFERED
  • 10.6.4 KEY DEVELOPMENTS
  • 10.6.5 KEY STRATEGIES
• 10.7 ADVANCED STERILIZATION PRODUCTS
  • 10.7.1 COMPANY OVERVIEW
  • 10.7.2 FINANCIAL OVERVIEW
  • 10.7.3 PRODUCTS OFFERED
  • 10.7.4 KEY DEVELOPMENTS
  • 10.7.5 KEY STRATEGIES
• 10.8 NEOGEN CORPORATION
  • 10.8.1 COMPANY OVERVIEW
  • 10.8.2 FINANCIAL OVERVIEW
  • 10.8.3 PRODUCTS OFFERED
  • 10.8.4 KEY DEVELOPMENTS
  • 10.8.5 SWOT ANALYSIS
  • 10.8.6 KEY STRATEGIES
• 10.9 CARDINAL HEALTH
  • 10.9.1 COMPANY OVERVIEW
  • 10.9.2 FINANCIAL OVERVIEW
  • 10.9.3 PRODUCTS OFFERED
  • 10.9.4 KEY DEVELOPMENTS
  • 10.9.5 KEY STRATEGIES
• 10.10 STRYKER
  • 10.10.1 COMPANY OVERVIEW
  • 10.10.2 FINANCIAL OVERVIEW
  • 10.10.3 PRODUCTS OFFERED
  • 10.10.4 KEY DEVELOPMENTS
  • 10.10.5 KEY STRATEGIES

11 DATA CITATIONS